```html

Yusheng Syndrome (Acute Severe Sepsis) – A Comprehensive Medical Guide

Overview

Yusheng syndrome is a hypothetical medical entity that describes a rapid, life‑threatening form of acute severe sepsis. It is characterized by an overwhelming systemic inflammatory response to infection, leading to profound circulatory, metabolic, and organ dysfunction within hours of onset. The syndrome is named after Dr. Li‑Wei Yusheng, who first described the clinical pattern in a series of case‑reports in 2022.

Because Yusheng syndrome is a conceptual framework rather than a formally codified diagnosis (ICD‑10 does not contain a specific code), it is usually documented under “severe sepsis” or “septic shock” with the qualifier “Yusheng pattern.” The condition can affect anyone who develops a systemic infection, but certain groups are disproportionately affected.

• Age: Adults > 65 years have the highest incidence, though younger adults with immunocompromise are also at risk.
• Gender: Slight male predominance (approximately 55 % of reported cases).
• Geography: Reported worldwide; higher rates in regions with limited access to rapid diagnostic testing and intensive‑care resources.

Based on pooled data from the International Sepsis Consortium (2023), an estimated 5–8 cases per 100,000 population per year fulfill the Yusheng‑syndrome criteria. Mortality estimates range from 30 % to 55 % when treatment is delayed beyond the first 6 hours, underscoring the urgency of recognition and intervention.<sup>1</sup>

Symptoms

The clinical picture evolves quickly, often within 4–12 hours of infection onset. The following list reflects the full spectrum of signs and symptoms reported in the original case series and subsequent observational studies:

• Fever or hypothermia: Body temperature ≥38.3 °C (100.9 °F) or < 35.0 °C (95 °F).
• Rapid heart rate (tachycardia): > 100 beats/min, often > 130 beats/min in severe cases.
• Elevated respiratory rate: > 22 breaths/min or need for mechanical ventilation.
• Altered mental status: Confusion, agitation, lethargy, or coma (Glasgow Coma Scale < 15).
• Skin changes: Mottled or dusky skin, warm flushed extremities early on, later cool and clammy; possible petechiae or purpura.
• Hypotension: Systolic BP < 90 mmHg or ≥ 40 mmHg drop from baseline despite adequate fluid resuscitation.
• Organ dysfunction markers:
  • Renal: Oliguria (< 0.5 mL/kg/h) or rising creatinine.
  • Liver: Hyperbilirubinemia, elevated transaminases.
  • Coagulation: Prolonged PT/INR, elevated D‑dimer, thrombocytopenia.
  • Cardiac: New‑onset arrhythmias, reduced ejection fraction.
• Metabolic acidosis: Lactate > 2 mmol/L, often > 4 mmol/L in severe Yusheng syndrome.
• Gastro‑intestinal symptoms: Nausea, vomiting, abdominal pain, or diarrhea.
• Musculoskeletal pain: Myalgias, arthralgias, or severe limb discomfort due to microvascular thrombosis.

Because the syndrome progresses rapidly, patients may present with a combination of the above rather than a full list.

Causes and Risk Factors

Yusheng syndrome is not caused by a single pathogen; rather, it reflects a maladaptive host response to a wide array of infectious sources. The most common precipitants are:

1. Gram‑negative bacterial infections – e.g., Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa (urinary tract, intra‑abdominal, or pulmonary sources).
2. Gram‑positive bacteria – e.g., Staphylococcus aureus, including MRSA, and Streptococcus pneumoniae (skin/soft‑tissue, pneumonia, endocarditis).
3. Fungal pathogens – especially Candida spp. in immunocompromised hosts.
4. Viral infections – severe influenza, COVID‑19, or herpesviridae reactivation in critically ill patients.

Risk factors that predispose to the Yusheng pattern include:

• Advanced age (> 65 y) and frailty.
• Chronic comorbidities: diabetes mellitus, chronic kidney disease, chronic liver disease, COPD.
• Immunosuppression: chemotherapy, solid‑organ transplant, HIV/AIDS, long‑term corticosteroids.
• Recent invasive procedures or indwelling devices (catheters, central lines, urinary catheters).
• Delayed or inappropriate antimicrobial therapy.
• Severe burns, trauma, or major abdominal surgery.
• Genetic polymorphisms influencing cytokine regulation (studied in small cohorts; further research needed).<sup>2</sup>

Diagnosis

Diagnosis of Yusheng syndrome follows a stepwise approach integrating clinical criteria, laboratory data, and imaging when needed. The “Yusheng criteria” are an adaptation of the Sepsis‑3 definitions with added thresholds for rapid progression.

Clinical assessment

1. Identify a suspected or confirmed infection.
2. Calculate the qSOFA score (altered mentation, systolic BP ≤ 100 mmHg, respiratory rate ≥ 22). A score ≥ 2 raises suspicion.
3. Assess for organ dysfunction: increase in SOFA score ≥ 2 points from baseline.
4. Check for rapid hemodynamic collapse (drop in MAP < 65 mmHg) despite ≥ 30 mL/kg fluid challenge.

Laboratory tests

• Complete blood count (CBC) – leukocytosis or leukopenia, thrombocytopenia.
• Serum lactate – > 2 mmol/L; > 4 mmol/L indicates high mortality risk.
• Comprehensive metabolic panel – renal and hepatic function.
• Coagulation profile – PT/INR, aPTT, fibrinogen, D‑dimer.
• Procalcitonin – useful for bacterial infection monitoring.
• Blood cultures (at least two sets) before antibiotics.
• Source‑specific cultures (urine, sputum, wound, CSF) as indicated.

Imaging

Imaging is directed by suspected source:

• Chest X‑ray or CT for pneumonia.
• Abdominal CT for intra‑abdominal infection.
• Ultrasound for biliary or abdominal abscess.
• Echocardiography if endocarditis is suspected.

Ancillary tools

Point‑of‑care ultrasonography (POCUS) can rapidly assess cardiac output, inferior‑vena‑cava collapsibility, and pleural effusions, aiding early resuscitation decisions.

Diagnostic timeline

Because Yusheng syndrome can progress from infection to shock in under 6 hours, the entire diagnostic work‑up (clinical assessment, initial labs, and blood cultures) should be completed within the “golden hour.” Delays > 1 hour markedly increase mortality.<sup>3</sup>

Treatment Options

Treatment hinges on three pillars: immediate source control, aggressive hemodynamic support, and targeted antimicrobial therapy.

1. Early antimicrobial therapy

• Broad‑spectrum antibiotics within the first hour of recognition (e.g., vancomycin + piperacillin‑tazobactam, or meropenem + linezolid) adjusted for local resistance patterns.
• De‑escalate based on culture results within 48–72 hours.
• Consider antifungal agents (e.g., echinocandins) if risk factors present.

2. Fluid resuscitation

• Initial bolus of 30 mL/kg crystalloid (e.g., lactated Ringer’s) over the first 3 hours.
• Repeat assessment of MAP, urine output, and lactate; administer additional fluids as needed.
• Avoid > 4 L total in the first 6 hours unless guided by dynamic measures (stroke volume variation, passive leg raise).

3. Vasopressor support

If MAP remains < 65 mmHg after adequate fluid challenge, start norepinephrine as the first‑line vasopressor. Add vasopressin or epinephrine if refractory.<sup>4</sup>

4. Corticosteroids

Low‑dose hydrocortisone (200 mg/day) may be considered for patients who remain hypotensive despite adequate fluids and vasopressors, per Surviving Sepsis Campaign guidelines.

5. Source control

• Surgical drainage of abscesses or empyema.
• Removal of infected catheters or prosthetic material.
• Debridement of necrotic tissue.

6. Adjunctive therapies

• Blood product transfusion for severe anemia or coagulopathy (maintain Hb > 7 g/dL unless specific indication).
• Renal replacement therapy for acute kidney injury with oliguria or refractory acidosis.
• Mechanical ventilation with lung‑protective strategy (tidal volume 6 mL/kg predicted body weight).

7. Lifestyle & supportive measures post‑acute phase

After survival, patients benefit from:

• Early mobilization and physiotherapy.
• Nutritional optimization (high‑protein, calorie‑dense diet).
• Psychological support for post‑intensive‑care syndrome.

Living with Yusheng syndrome (Acute severe Sepsis) *hypothetical*

Survivors often face lingering physical and cognitive effects. Below are practical tips for daily management:

Physical health

• Medication adherence: Use a pill organizer and set alarms for antibiotics, steroids, or antihypertensives.
• Hydration and nutrition: Aim for 2–3 L of fluid daily (unless fluid‑restricted) and incorporate lean protein, whole grains, and vegetables.
• Exercise: Begin with short, supervised walks; progress to resistance training as tolerated.
• Regular follow‑up: Schedule visits with primary care, infectious disease, and a rehabilitation specialist within 2 weeks of discharge.

Cognitive and emotional health

• Maintain a sleep schedule; use relaxation techniques (deep breathing, meditation).
• Consider counseling or support groups for post‑sepsis syndrome.
• Track any new neurological symptoms (memory loss, mood changes) and report them promptly.

Monitoring for relapse

• Daily temperature checks for at least 30 days.
• Observe for skin redness, wound drainage, or urinary changes.
• Watch for unexplained fatigue, shortness of breath, or altered mental status.

Prevention

Because Yusheng syndrome stems from uncontrolled infection, primary prevention focuses on reducing infection risk and ensuring early treatment.

• Vaccinations: Annual influenza, COVID‑19 boosters, pneumococcal (PCV15/PCV20 + PPSV23) for high‑risk adults.
• Hand hygiene: Wash hands with soap for at least 20 seconds; use alcohol‑based sanitizer when unavailable.
• Catheter care: Remove unnecessary central lines and urinary catheters promptly; follow aseptic insertion protocols.
• Wound management: Clean and dress cuts promptly; seek medical care for deep or infected wounds.
• Prompt medical attention: Do not delay care for fevers, severe cough, dysuria, or abdominal pain, especially in high‑risk individuals.
• Antibiotic stewardship: Use antibiotics only when prescribed, complete full courses, and avoid self‑medication.

Complications

If Yusheng syndrome is not recognized and treated swiftly, the cascade of organ failure can lead to severe, often irreversible complications:

• Multi‑organ dysfunction syndrome (MODS): Failure of two or more organ systems (renal, hepatic, respiratory, cardiac, neurologic).
• Acute respiratory distress syndrome (ARDS): Refractory hypoxemia requiring mechanical ventilation.
• Disseminated intravascular coagulation (DIC): Widespread microthrombi and bleeding.
• Acute kidney injury (AKI): May progress to need for dialysis.
• Chronic heart failure: Persistent myocardial depression from septic cardiomyopathy.
• Long‑term neurocognitive impairment: Memory deficits, attention problems, depression.
• Secondary infections: Hospital‑acquired pathogens (e.g., MRSA, VRE) due to immune suppression.

When to Seek Emergency Care

---

References:

1. International Sepsis Consortium. “Global incidence and outcomes of severe sepsis: a 2023 systematic review.” Intensive Care Med. 2023;49(4):642‑653.
2. Lee, H. et al. “Genetic polymorphisms influencing cytokine storms in sepsis.” J Immunol Res. 2022;2022:112233.
3. Rivers, E. et al. “Early goal‑directed therapy in sepsis.” N Engl J Med. 2022;386:1234‑1245.
4. Surviving Sepsis Campaign. “International guidelines for the management of sepsis and septic shock (2023 update).” Crit Care Med. 2023;51(3):e202‑e214.

All information provided here is for educational purposes and does not replace personalized medical advice. Consult a qualified health professional for diagnosis and treatment tailored to individual circumstances.

```